ServiceUpdated on 6 November 2025
CheckEye – AI-based Fundus Screening Platform
Social media and HR assistant at CheckEye Deutschland
München, Germany
About
CheckEye is a vendor-agnostic, AI-powered platform for early detection of chronic diseases based on retinal images.
We enable fast, accessible, and large-scale screening for diabetic retinopathy and other conditions, directly in pharmacies, optical stores, or diabetes centers – without the need for medical training.
Key advantages:
-
95%+ accuracy, including early-stage detection of diabetic retinopathy
-
Compatible with most fundus cameras – no proprietary hardware needed
-
Real-time results & personalized risk reports for patients
-
Built-in tools for telemedicine, referrals, and follow-up appointments
-
Ideal for preventive care programs, nationwide screenings, or retail health initiatives
We offer flexible B2B2C implementation models and support our partners along the full patient journey.
Let’s connect to explore how we can bring preventive eye care to your region or network.
Applies to
- LIFE SCIENCE
- ROBOTICS AND AUTOMATION
Similar opportunities
Partnership
White-Label and Partnership Opportunities in Hypertension Care
- Business
- Franchising
- Knowledge transfer
Leo Rosenbaum
CEO at Heartery
Copenhagen, Denmark
Expertise
Robertas Damasevicius
Professor at Kaunas University of Technology
Kaunas, Lithuania
Product
MEDPOI - Innovative AI-powered ER patients management system.
- Buyer
- MEDICINE
- LIFE SCIENCE
- Subcontractor
- Re-Seller/Wholesaler
- Demonstration / Pilot projects
Hara Pylarinou
CEO at CAREPOI
Patras, Greece